Neonatal Abstinence Syndrome — Donor Human Milk in Neonatal Abstinence Syndrome
Citation(s)
Alexander C, Radmacher P, Devlin L Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Pregnancy and neonatal medicine 2017; 1(1):11-15.
Billeaud C, Guillet J, Sandler B Gastric emptying in infants with or without gastro-oesophageal reflux according to the type of milk. Eur J Clin Nutr. 1990 Aug;44(8):577-83.
Cavell B Gastric emptying in infants fed human milk or infant formula. Acta Paediatr Scand. 1981 Sep;70(5):639-41.
COBRINIK RW, HOOD RT Jr, CHUSID E The effect of maternal narcotic addiction on the newborn infant; review of literature and report of 22 cases. Pediatrics. 1959 Aug;24(2):288-304.
Kron RE, Finnegan LP, Kaplan SL, Litt M, Phoenix MD The assessment of behavioral change in infants undergoing narcotic withdrawal: comparative data from clinical and objective methods. Addict Dis. 1975;2(1-2):257-75.
Neonatal drug withdrawal American Academy of Pediatrics Committee on Drugs. Pediatrics. 1998 Jun;101(6):1079-88. Erratum in: Pediatrics 1998 Sep;102(3 Pt 1):660.
Nestler EJ Molecular mechanisms of opiate and cocaine addiction. Curr Opin Neurobiol. 1997 Oct;7(5):713-9. Review.
Perez-Reyes M, Wall ME Presence of delta9-tetrahydrocannabinol in human milk. N Engl J Med. 1982 Sep 23;307(13):819-20.
Rodriguez-Palmero M, Koletzko B, Kunz C, Jensen R Nutritional and biochemical properties of human milk: II. Lipids, micronutrients, and bioactive factors. Clin Perinatol. 1999 Jun;26(2):335-59. Review.
Section on Breastfeeding Breastfeeding and the use of human milk. Pediatrics. 2012 Mar;129(3):e827-41. doi: 10.1542/peds.2011-3552. Epub 2012 Feb 27. Review.
Sheard NF, Walker WA The role of breast milk in the development of the gastrointestinal tract. Nutr Rev. 1988 Jan;46(1):1-8. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
